Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
160,529,963
-
Number of holders
-
88
-
Total 13F shares, excl. options
-
48,612,900
-
Shares change
-
-2,345,574
-
Total reported value, excl. options
-
$83,616,963
-
Value change
-
-$4,321,407
-
Put/Call ratio
-
64%
-
Number of buys
-
36
-
Number of sells
-
37
-
Price
-
$1.72
Institutional Holders of Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) as of Q3 2023
As of 30 Sep 2023 Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) had 88 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 48,612,900 shares of stock of the company.
Largest 10 holders included Redmile Group, LLC, BlackRock Inc., Point72 Asset Management, L.P., VANGUARD GROUP INC, Versant Venture Management, LLC, Avidity Partners Management LP, Balyasny Asset Management L.P., GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, and STATE STREET CORP.
This table shows 88 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.